Speaker Profile
Ph.D., CEO, Bento Biology
Biography
Kelly M. McVearry, PhD, is Co-Founder and CEO of Bento Biology Platforms, a biotechnology company advancing decentralized clinical trials and inclusive precision medicine. A neuroscientist, technology executive, and patient advocate, she developed Bento's platform to expand participation in clinical research through at-home biosampling and digital patient engagement. Previously, she held leadership positions at Northrop Grumman Health Information Systems and Ekagra Software, where she helped advance clinical trial data technologies used in FDA regulatory review. She served as inaugural Chair of Lupus Therapeutics and on the NIH National Center for Advancing Translational Sciences Advisory Council. Dr. McVearry earned her PhD in Neuroscience from Georgetown University and a master's degree in Cognitive Psychology from Harvard University.
AI and Data Sciences Showcase:
Bento Biology
Session Abstract – PMWC 2027 Silicon Valley
The PMWC 2027 AI Company Showcase will provide a 15-30 minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
